Michelle knew what was wrong. She knew the headaches, regular vomiting, ear popping, and “whooshing” sounds in her head were all signs of leptomeningeal disease (LMD). The issue, however, is that LMD is so rare—only diagnosed in 5% of people with cancer—she had to advocate for the testing to prove it.

“I called my clinic and said I needed a brain MRI because I think I have LMD. They didn’t want to schedule one, so I said, tell my doctor I’m demanding a brain MRI. I can tell him directly if I need to,” says Michelle.

What Is Integrative Oncology? 

Integrative oncology is the use of complementary therapies alongside conventional lung cancer treatments like chemotherapy, targ

On Friday, March 14, Christopher Kniese, MD, of IU Health, discussed the role of pulmonologists in SCLC, why the right diagnosis is key, logistics and importance of a bronchoscopy/biopsy, pulmonary rehab, and other topics.

Moderated by Misty Shields, MD, IU Health, and LUNGevity’s Ann Fish-Steagall, SVP of Patient Services and Health Care Delivery, this monthly virtual series highlights the latest discoveries and breakthroughs in SCLC.

On Friday, February 28, Drs. and Rekhtman of Memorial Sloan Kettering Cancer Center joined us on Facebook Live to discuss the role of pathologists in SCLC, why the right diagnosis is key, and the logistics and importance of biopsies. They explained forms of SCLC such as atypical, transformed, and RB proficient.

Moderated by Misty Shields, MD, PhD, IU Health, and LUNGevity’s Ann Fish-Steagall, SVP of Patient Services and Health Care Delivery, this monthly virtual series highlights the latest discoveries and breakthroughs in small cell lung cancer (SCLC).

Mya Tran, PharmD, BCOP, joined us in January to discuss what people should expect during treatment for small cell lung cancer (SCLC), managing side effects related to SCLC therapy, as well as the importance of genomics and its role in molecularly informed clinical trials for SCLC. Moderated by Dr. Misty Shields, IU Health, and LUNGevity’s Ann Fish-Steagall, SVP of Patient Services and Health Care Delivery, this monthly virtual series highlights the latest discoveries and breakthroughs in SCLC. 

Read time: 2 minutes. 

Researchers have been trying to find new ways to treat small cell lung cancer (SCLC) for a long time. Those efforts are starting to pay off in big ways.  

Join Stephen Liu, MD, of Georgetown Lombardi Comprehensive Cancer Center, and Amy Moore, PhD, of LUNGevity Foundation, as they walk us through the treatment options for SCLC, including exciting breakthroughs on the horizon.

Read time: 2 minutes.

Here we present the final video in our three-part series about how patients and researchers can work together to develop clinical trials.  

Read time: 2 minutes.  

We are pleased to continue our three-part series about how patients and researchers can work together to develop clinical trials.  

Read time: 3 minutes.

Throughout 2024 we published blogs sharing scientific meeting recaps, educational content, personal stories, treatment news, and so much more. Below are the most popular articles we published in 2024. 

Triparna Sen, PhD, Icahn School of Medicine at Mount Sinai, New York, joined us for our September Small Cell SMASHERS Facebook Live event. Dr. Sen discussed the biology and the role of biomarkers in small cell lung cancer. Moderated by Dr. Misty Shields, IU Health, and LUNGevity’s Ann Fish-Steagall, SVP of Patient Services and Health Care Delivery, this monthly virtual series highlights the latest discoveries and breakthroughs in small cell lung cancer (SCLC).